Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid
Abstract Lysosomal dysfunction is an emerging feature in the pathology of Parkinson’s disease and Dementia with Lewy bodies. Mutations in the GBA gene, encoding the enzyme Glucocerebrosidase (GCase), have been identified as a genetic risk factor for these synucleinopathies. As a result, there has be...
Guardado en:
Autores principales: | Linn Oftedal, Jodi Maple-Grødem, Marthe Gurine Gunnarsdatter Førland, Guido Alves, Johannes Lange |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/798cd8a5c2bd49debe0bb3fe4928aa98 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson’s disease
por: Camilla Christina Pedersen, et al.
Publicado: (2021) -
Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing
por: Franziska Bachhuber, et al.
Publicado: (2021) -
FLUOROMETRIC ASSAY FOR CELL PROLIFERATION IN HUMAN TUMOR CELL LINES APPLICATION
por: Linamaría Escobar M., et al.
Publicado: (2010) -
A Luminex assay detects amyloid β oligomers in Alzheimer's disease cerebrospinal fluid.
por: Adrianna Z Herskovits, et al.
Publicado: (2013) -
Cerebrospinal fluid research
Publicado: (2004)